期刊文献+

黑色素瘤相关抗原-A:食管癌免疫治疗新靶点 被引量:2

MAGE-A:New Target of Immunotherapy for Esophageal Cancer
下载PDF
导出
摘要 黑色素瘤相关抗原(melanoma-associated antigen,MAGE)-A亚家族是MAGE基因家族成员,属于癌睾丸抗原,包括MAGE-A1~MAGE-A12,定位于X染色体。MAGE-A在正常组织中几乎不表达,而在多种肿瘤组织中表达,其在食管癌细胞系和食管癌组织均有较高表达。MAGE-A基因编码的抗原肽可由食管癌细胞MHCⅠ分子提呈至细胞毒性T细胞,能够发挥特异性抗肿瘤活性。因此,以MAGE-A抗原为新靶点,对食管癌患者进行免疫治疗有良好的前景。 Melanoma-associated antigens-A(MAGE-A) are the subfamily of MAGE genes,locate in the human X chromosome and belong to cancer testis antigens(CTA),which are composed of 12 members,MAGE-A1-MAGE-A12.MAGE-A are rarely expressed in normal tissues,but frequently expressed in a variety of tumor tissues,especially highly expressed in esophageal cancer tissues and esophageal carcinoma cell lines.In addition,the peptides encoded by MAGE-A can be presented to cytotoxic T cells(CTL) by MHCⅠ molecules in esophageal cancer cells,which plays an important role in anti-tumor activity in a specific manner.Therefore,MAGE-A antigens are of great potential as a new target of immunotherapy in the treatment for esophageal cancer in the future.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2015年第6期622-626,共5页 Cancer Research on Prevention and Treatment
基金 河北省自然科学基金(H2012206077)
关键词 黑色素瘤相关抗原-A 食管癌 癌睾丸抗原 免疫治疗 Melanoma-associated antigen A(MAGE-A) Esophageal cancer Cancer testis antigen Immunotherapy
  • 相关文献

参考文献20

  • 1Deepa Kolaseri Krishnadas,Lei Bao,Fanqi Bai,Satheesh Cheeyancheri Chencheri,Kenneth Lucas.Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1[J]. Tumor Biology . 2014 (6)
  • 2Viswanath Gunda,Alexandria P. Cogdill,Maria J. Bernasconi,Jennifer A. Wargo,Sareh Parangi.Potential role of 5- aza-2’-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer[J]. Surgery . 2013
  • 3Chantal Mengus,Elke Schultz‐Thater,Julie Coulot,Zeljko Kastelan,Eleonora Goluza,Marijana Coric,Giulio C. Spagnoli,Tvrtko Hudolin.MAGE‐A10 cancer/testis antigen is highly expressed in high‐grade non‐muscle‐invasive bladder carcinomas[J]. Int. J. Cancer . 2012 (10)
  • 4Shirin Karimi,Foroozan Mohammadi,Mihan Porabdollah,Seyed Amir Mohajerani,Kian Khodadad,Seyed Alireza Nadji.Characterization of Melanoma-Associated Antigen-A Genes Family Differential Expression in Non-Small-Cell Lung Cancers[J]. Clinical Lung Cancer . 2012 (3)
  • 5NorihikoTakahashi,TakayukiOhkuri,ShigenoriHomma,JunyaOhtake,DaikoWakita,YujiTogashi,HidemitsuKitamura,SatoruTodo,TakashiNishimura.First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen[J]. Cancer Science . 2012 (1)
  • 6Zheng-Cai Jia,Bing Ni,Ze-Min Huang,Yi Tian,Jun Tang,Jing-Xue Wang,Xiao-Lan Fu,Yu-Zhang Wu,Graham Ogg.Identification of Two Novel HLA-A<sup> ? </sup>0201-Restricted CTL Epitopes Derived from MAGE-A4[J]. Clinical and Developmental Immunology . 2010
  • 7MarijaPastorcic‐Grgic,BozenaSarcevic,DanijelDosen,AntonioJuretic,Giulio C.Spagnoli,MarkoGrgic.Prognostic value of MAGE‐A and NY‐ESO‐1 expression in pharyngeal cancer[J]. Head Neck . 2010 (9)
  • 8Xiu-Min Zhang,Yang Huang,Zeng-Shan Li,Hui Lin,Yan-Fang Sui.Prediction and analysis of HLA-A2/A24-restricted cytotoxic T-lymphocyteepitopes of the tumor antigen MAGE-n using the artificial neural networks methodon NetCTL1.2 Server[J]. Oncology Letters . 2010 (6)
  • 9Stacey N Akers,Kunle Odunsi,Adam R Karpf.Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy[J]. Future Oncol. . 2010 (5)
  • 10ArgunAkcakanat,TatsuoKanda,TadashiTanabe,ShintarouKomukai,KazuhitoYajima,SatoruNakagawa,ManabuOhashi,KatsuyoshiHatakeyama.Heterogeneous expression of GAGE, NY‐ESO‐1, MAGE‐A and SSX proteins in esophageal cancer: Implications for immunotherapy[J]. Int. J. Cancer . 2005 (1)

共引文献1

同被引文献12

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部